Could the suspension of patents for anti-Covid vaccines be a solution to accelerate the global distribution of vaccines?
Covid, is it really possible to liberalize patents for vaccines? The reasons for yes and no
Pasquale Frega, president and CEO of Novartis in Italy, Silvia Mancini, public health expert at Doctors Without Borders, and Chiara Franzoni, professor of patents and intellectual property at the Milan Polytechnic, answered
